MolNFT v1 · #29004 · protein
The plasmodium falciparum cysteine protease falcipain-2
1YVB · Falcipain 2: “The plasmodium falciparum cysteine protease falcipain-2”. X-ray diffraction, 3 pockets (best druggability 0.52). MolNFT v1 #29004 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1YVB
- Type
- protein
- Length
- 352 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Falcipain 2; Cystatin
- EC
- 3.4.22.-
- UniProt
- Q9N6S8, P01038
- Pockets
- 3 · best druggability 0.52
Structure
x-ray diffraction · 2 distinct chains · 23% helix, 29% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Falcipain 2 (EC 3.4.22.-) | protein | 241 | 26% helix, 24% strand | Q9N6S8 |
| I | Cystatin | protein | 111 | 18% helix, 40% strand | P01038 |
Ligands and binding sites
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 131 | 0.52 | 0.81 | 27 | empty |
| 2 | 167 | 0.48 | 0.77 | 31 | empty |
| 3 | 76 | 0.34 | 0.76 | 13 | empty |
Interfaces
1 interface between chains.
- A–I · 922 Ų buried · 7 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 6 disulfide, 1 covalent (disulfide, additive adduct).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9N6S8
- Every structure of UniProt P01038
- Elsewhere: RCSB PDB 1YVB · PDBe 1YVB · UniProt Q9N6S8 · UniProt P01038
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.